NM001(Lynovex®) is a first-in-class orphan drug candidate for cystic fibrosis. NM001 is unique, providing the first of its kind treatment for cystic fibrosis (and also COPD and other chronic respiratory conditions), as a single treatment with multi-functi

NM001(Lynovex®) is a first-in-class orphan drug candidate for cystic fibrosis. NM001 is unique, providing the first of its kind treatment for cystic fibrosis (and also COPD and other chronic respiratory conditions), as a single treatment with multi-functi